Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption
Author:
Affiliation:
1. School of Pharmacy, Pharmacology Unit; University of Camerino; Italy
2. Committee on the Neurobiology of Addictive Disorders; The Scripps Research Institute; La Jolla CA USA
3. Astraea Therapeutics; Mountain View CA USA
Funder
National Institutes of Health
Publisher
Wiley
Subject
Psychiatry and Mental health,Pharmacology,Medicine (miscellaneous)
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/adb.12513/fullpdf
Reference54 articles.
1. Orphanin FQ/nociceptin not only blocks but also reverses behavioral adaptive changes induced by repeated cocaine in mice;Bebawy;Biol Psychiatry,2010
2. Mixed kappa/mu partial opioid agonists as potential treatments for cocaine dependence;Bidlack;Adv Pharmacol,2014
3. Agonistic effects of the opioid buprenorphine on the nociceptin/OFQ receptor;Bloms-Funke;Peptides,2000
4. Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system;Ciccocioppo;Biol Psychiatry,2007
5. A key role for the N/OFQ-NOP receptor system in modulating nicotine taking in a model of nicotine and alcohol co-administration;Cippitelli;Sci Rep,2016
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy;Neuropharmacology;2024-10
2. Effect of chronic delivery of the NOP/MOR partial agonist AT-201 and NOP antagonist J-113397 on heroin relapse in a rat model of opioid maintenance;Psychopharmacology;2024-09-13
3. Cebranopadol: An Assessment for Its Biased Activation Potential at the Mu Opioid Receptor by DFT, Molecular Docking and Molecular Dynamic Simulation Studies;ChemistrySelect;2023-10-06
4. Cebranopadol, a novel long-acting opioid agonist with low abuse liability, to treat opioid use disorder: Preclinical evidence of efficacy;2023-07-25
5. Buprenorphine reduces methamphetamine intake and drug seeking behavior via activating nociceptin/orphanin FQ peptide receptor in rats;Frontiers in Psychiatry;2022-10-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3